BMJ Group announces partnership with Epocrates

The BMJ Group and Epocrates, Inc., a US-based provider of clinical information products and services, today announced an exclusive development and marketing partnership. The companies are introducing new online clinical reference products to the US market with a unique patient-centered approach to assist clinicians in making critical treatment decisions at the immediate point of care.  Through the partnership, BMJ Group’s experienced editorial team is collaborating with physician authors to create comprehensive disease diagnosis and treatment monographs. In addition to clear, concise expert opinions, the monographs also contain links to the medical evidence in BMJ Clinical Evidence.

"BMJ Group is delighted to be working with Epocrates, a recognised US leader in point-of-care healthcare technology”, said Stella Dutton, chief executive officer for BMJ Group. "This is a tremendous opportunity for us to combine our strengths to provide clinicians with accurate and relevant diagnosis and treatment information where and when they need it most.”  
The BMJ Group plans to make these products available in the UK and internationally during the early part of next year.

This announcement follows recent partnership announcements by the BMJ Group with MSD and Boots. The partnership with MSD’s medical portal univadis ® will enable  BMJ Learning to be available to physicians in 33 countries. The partnership with Boots provides the general public in the UK access to BMJ Best Treatments, the authoritative evidence based information for patients, via the Boots website “askboots.com”.

Notes to Editors:

BMJ Group is one of the world's leading providers of trusted medical information for healthcare professionals and patients. BMJ Group publishes BMJ (British Medical Journal), over 25 specialist journals, BMJ Clinical Evidence and BMJ Best Treatments (currently available in the UK from AskBoots.com). The Group also provides through BMJ Learning, continuing professional development online modules and exam revision materials, as well as events and workshops for the healthcare profession. BMJ Group is owned by the British Medical Association. It is editorially independent and the articles and content it publishes are not intended to reflect BMA policy.

Epocrates is a leading provider of clinical information and decision support tools to healthcare professionals. Epocrates currently has more than 500,000 active subscribers worldwide, including more than one in four U.S. physicians and more than one in three U.S. medical students. The company’s subscription-based services enable healthcare professionals to make more informed medical decisions, reduce medical errors and practice more efficiently. For more information about Epocrates, please see http://www.epocrates.com/company

For further information please contact:

Rachael Davies
email: rdavies@bma.org.uk

British Medical Journal
BMA House
Tavistock Square
London
WC1H 9JP

Trish Joyce

email: tjoyce@bmjgroup.com

BMJ Publishing, Inc.
10694 E. Berry Avenue
Greenwood Village, CO  80111
USA